Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry
- 1 April 2015
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 184, 717-723
Abstract
No abstract availableKeywords
Funding Information
- Bayer Schering
This publication has 28 references indexed in Scilit:
- Lung function and gas exchange in Eisenmenger syndrome and their impact on exercise capacity and survivalInternational Journal of Cardiology, 2014
- Pulmonary hypertension related to congenital heart disease: a call for actionEuropean Heart Journal, 2013
- Six-minute walk test distance and resting oxygen saturations but not functional class predict outcome in adult patients with Eisenmenger syndromeInternational Journal of Cardiology, 2013
- Disease targeting therapies in patients with Eisenmenger syndrome: Response to treatment and long-term efficiencyInternational Journal of Cardiology, 2013
- Echocardiographic Predictors of Outcome in Eisenmenger SyndromeCirculation, 2012
- B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapyHeart, 2012
- Improved Survival Among Patients With Eisenmenger Syndrome Receiving Advanced Therapy for Pulmonary Arterial HypertensionCirculation, 2010
- Longer-term bosentan therapy improves functional capacity in Eisenmenger syndrome: Results of the BREATHE-5 open-label extension studyInternational Journal of Cardiology, 2008
- Pulmonary Vascular Disease in Adults With Congenital Heart DiseaseCirculation, 2007
- Bosentan Therapy in Patients With Eisenmenger SyndromeCirculation, 2006